Acute high‐intensity muscle contraction moderates AChR gene expression independent of rapamycin‐sensitive mTORC1 pathway in rat skeletal muscle
Experimental Physiology · 2025
DOI: 10.1113/ep091006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, 2025. Verfasst von Yuhei Makanae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Education, National Defence Academy, Yokosuka, Japan. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Muscle Contraction, Rats, Sprague-Dawley, Muscle, Skeletal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
The relationship between mechanistic target of rapamycin complex 1 (mTORC1) activation after resistance exercise and acetylcholine receptor (AChR) subunit gene expression remains largely unknown. Therefore, we aimed to investigate the effect of electrical stimulation‐induced intense muscle contraction, which mimics acute resistance exercise, on the mRNA expression of AChR genes and the signalling pathways involved in neuromuscular junction (NMJ) maintenance, such as mTORC1 and muscle‐specific kinase (MuSK). The gastrocnemius muscle of male adult Sprague–Dawley rats was isometrically exercised. Upon completion of muscle contraction, the rats were euthanized in the early (after 0, 1, 3, 6 or 24 h) and late (after 48 or 72 h) recovery phases and the gastrocnemius muscles were removed. Non‐exercised control animals were euthanized in the basal state (control group). In the early recovery phase, Agrn gene expression increased whereas LRP4 decreased without any change in the protein and gene expression of AChR gene subunits. In the late recovery phase, Agrn , Musk , Chrnb1, Chrnd and Chrne gene expression were altered and agrin and MuSK protein expression increased. Moreover, mTORC1 and protein kinase B/Akt‐histone deacetylase 4 (HDAC) were activated in the early phase but not in the late recovery phase. Furthermore, rapamycin, an inhibitor of mTORC1, did not disturb changes in AChR subunit gene expression after muscle contraction. However, rapamycin addition slightly increased AChR gene expression, while insulin did not impact it in rat L6 myotube. These results suggest that changes in the AChR subunits after muscle contraction are independent of the rapamycin‐sensitive mTORC1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Education, National Defence Academy, Yokosuka, Japan.
- Department of Life Science and Applied Chemistry, Nagoya Institute of Technology, Nagoya, Japan.
- Japan Society for the Promotion of Science, Tokyo, Japan.
- Healty Food Science Research Group, Cellular and Molecular Biotechnology Research Institute, Industrial Science and Technology (AIST), Tsukuba, Japan.
- Faculty of Health and Sports Sciences, Toyo University, Tokyo, Japan.
- Faculty of Medical Science, Nippon Sport Science University, Tokyo, Japan.
ORCID-Profile: Yuhei Makanae, Satoru Ato, Koichi Nakazato
Förderung
- JSPS KAKENHI
Zitieren
APA
Makanae, Y., Ato, S., Kouzaki, K., Tamura, Y., & Nakazato, K. (2025). Acute high‐intensity muscle contraction moderates AChR gene expression independent of rapamycin‐sensitive mTORC1 pathway in rat skeletal muscle. Experimental Physiology. https://doi.org/10.1113/ep091006
Vancouver
Makanae Y, Ato S, Kouzaki K, Tamura Y, Nakazato K. Acute high‐intensity muscle contraction moderates AChR gene expression independent of rapamycin‐sensitive mTORC1 pathway in rat skeletal muscle. Experimental Physiology. 2025. doi:10.1113/ep091006
BibTeX
@article{Makanae2025,
author = {Makanae, Yuhei and Ato, Satoru and Kouzaki, Karina and Tamura, Yuki and Nakazato, Koichi},
title = {Acute high‐intensity muscle contraction moderates AChR gene expression independent of rapamycin‐sensitive mTORC1 pathway in rat skeletal muscle},
journal = {Experimental Physiology},
year = {2025},
doi = {10.1113/ep091006}
}
EUVIMED